Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160032/S014

Lifeline/ReviveR DDU-100, Lifeline/ReviveR AUTO DDU-120, Lifeline/ReviveR VIEW DDU-2300, Lifeline/ReviveR VIEW AUTO DDU-

Defibtech, LLC · Decision date Jul 24, 2026

FDA DECISIONP160032/S014

What did the FDA approve?

FDA records P160032/S014 as a supplement to PMA P160032, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Jul 24, 2026.

FDA approval order statement

extending the Defibtech DDU-2000 series AED to the new VIEW 2 series which include models: Lifeline VIEW 2 model DDU-2950, Lifeline VIEW 2 AUTO DDU-2955, Lifeline ECG 2 DDU-2960, and the Universal Pads accessory model DDP-2004.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Jul 24, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P160032/S014
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
APPR
Decision date
Jul 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P160032/S014 received

    Application receipt date recorded by FDA.

  2. P160032/S015 · Related supplement

    Defibtech Lifeline; Defibtech Lifeline AUTO; Defibtech Lifeline VIEW; Defibtech Lifeline VIEW AUTO; Defibtech Lifeline E

  3. P160032/S016 · Related supplement

    Defibtech Automated External Defibrillator (AED) Systems

  4. P160032/S014 · FDA decision

    Normal 180 Day Track

  5. P160032/S017 · Related supplement

    Lifeline VIEW 2, Lifeline VIEW 2 AUTO and Lifeline ECG 2 AED

Timeline entries are records held by MedtechLedger for P160032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160032

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Defibtech, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
741 Boston Post Rd., Suite 201, Guilford, CT, 06437

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records